The article focuses on GE HealthCare's Q4 2024 earnings, specifically looking at key metrics beyond the usual estimates. This suggests that investors and analysts are seeking a more comprehensive understanding of the company's performance, which could influence investor sentiment. However, without specific data or results, the immediate impact on stock price is neutral.